Poland· PL-100026982

Glucardiamid

A nikethamide product containing nicethamidum + glucosum, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 2 of our 19 countries.

ATC R07AB02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedGlucardiamidATCR07AB02REGISTER NO.PL-100026982PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Nikethamide is registered in 2 of 19 countries.

Countries holding a registration under ATC R07AB02 (nikethamide), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Nikethamide · ATC R07AB02

2 / 19 countries

  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Nicethamidum + Glucosum
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Country
Poland (PL)
ATC code
R07AB02
ATC class
Nikethamide
Defined daily dose
0.5 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990199426
  • gtin
    05909990199419

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Nikethamide in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nikethamide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3ea5cb4e-d236-4bea-9ff0-b570d7fb8b1e
GET /v1/drugs/3ea5cb4e-d236-4bea-9ff0-b570d7fb8b1e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pastylki",
  "source": "urpl",
  "strength": "1500 mg + 125 mg",
  "packaging": "05909990199426 ¦ OTC ¦ 4328\n20 pastylek\n05909990199419 ¦ OTC ¦ 13425\n10 pastylek",
  "substance": "Nicethamidum 125 mg + Glucosum 1500 mg",
  "common_name": "Nicethamidum + Glucosum",
  "pl_product_id": "100026982",
  "pozwolenie_nr": "01994",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about nikethamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.